Patents Assigned to KYONGBO PHARM
  • Patent number: 10252993
    Abstract: The present invention provides a novel crystalline form of [R—(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Grant
    Filed: February 24, 2017
    Date of Patent: April 9, 2019
    Assignee: KYONGBO PHARM
    Inventors: Kyung Ju Lee, Hoe Joo Son, Doo Seong Choi, Sun Ho Chang, Do Yeon Oh
  • Publication number: 20180009747
    Abstract: The present invention provides a novel crystalline form of [R—(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Application
    Filed: February 24, 2017
    Publication date: January 11, 2018
    Applicant: KYONGBO PHARM
    Inventors: Kyung Ju LEE, Hoe Joo SON, Doo Seong CHOI, Sun Ho CHANG, Do Yeon OH
  • Publication number: 20140100375
    Abstract: The present invention provides a novel crystalline form of [R—(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-mthylethyl)-3 -phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Application
    Filed: December 13, 2013
    Publication date: April 10, 2014
    Applicant: KYONGBO PHARM
    Inventors: Kyung Ju LEE, Hoe Joo SON, Doo Seong CHOI, Sun Ho CHANG, Do Yeon OH
  • Publication number: 20140081033
    Abstract: The present invention provides a novel crystalline form of [R-(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-mthylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Application
    Filed: November 20, 2013
    Publication date: March 20, 2014
    Applicant: KYONGBO PHARM
    Inventors: Kyung Ju Lee, Hoe Joo Son, Doo Seong Choi, Sun Ho Chang, Do Yeon Oh
  • Publication number: 20120123132
    Abstract: The present invention provides a novel crystalline form of [R-(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-mthylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Application
    Filed: January 27, 2012
    Publication date: May 17, 2012
    Applicant: KYONGBO PHARM
    Inventors: Kyung Ju LEE, Hoe Joo SON, Doo Seong CHOI, Sun Ho CHANG, Do Yeon OH
  • Publication number: 20120029207
    Abstract: The present invention provides a novel crystalline form of [R—(R*,R*)]-2-(4-fluorophenyl)-?,?-dihydroxy-5-(1-mthylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-heptanoic acid hemi-calcium salt (atorvastatin hemi-calcium salt) of the following formula 1, which is known to be useful as a drug, a hydrate thereof and a preparation method thereof:
    Type: Application
    Filed: January 24, 2011
    Publication date: February 2, 2012
    Applicant: KYONGBO PHARM
    Inventors: Kyung Ju Lee, Hoe Joo Son, Doo Seong Choi, Sun Ho Chang, Do Yeon Oh